Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer
Satoshi Owada(The University of Tokyo), Masayuki Tatemichi(Tokai University)
Cited by 11
Related Papers
Critical Role of H2O2 Generated by NOX4 during Cellular Response under Glucose Deprivation
|PLoS ONE|2013|25
Autophagy‑mediated adaptation of hepatocellular carcinoma cells to hypoxia‑mimicking conditions constitutes an attractive therapeutic target
|Oncology Reports|2018|13
An Adaptation System to Avoid Apoptosis via Autophagy Under Hypoxic Conditions in Pancreatic Cancer Cells
|Anticancer Research|2017|11
Branched-chain amino acids govern the high learning ability phenotype in Tokai high avoider (THA) rats
|Scientific Reports|2021|7
Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells
|Anticancer Research|2021|3